Witnesses testified about the benefits of providing prescription drug benefits for Medicare recipients. They focused on the increasing cost of developing new drugs and how this cost increase affects prescription coverage for many Americans. They also talked about how Medicare would pay for the prescription benefit. 1723 Dummit, Gluck, Concannon panel (1:33) 1856 Mellion, Sanders, Holmer, Read, McSteen panel (0:58)